Potency-enhancing drugs linked to decreased risks in men with colorectal cancer
Published 12 October 2020 A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications. Wuq
https://www.lucc.lu.se/article/potency-enhancing-drugs-linked-decreased-risks-men-colorectal-cancer - 2025-03-13